Blackrock Funds · net assets $6.53B · 165 holdings as of February 27, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 97.5% · STIV: 1.4% · EP: 1.1% · OTHER: 0.0% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $96.3M | $69.6M | $47.1M |
| Reinvestment | $249M | $0 | $0 |
| Redemptions | $173M | $146M | $129M |
| Net realized gain (non-derivative) | $148M | $98.4M | $9.42M |
| Net unrealized appreciation (non-derivative) | $-286M | $-90.7M | $137M |
The three months of the reporting period, as filed; month 3 ends February 27, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly & Co. EC | $741M | 11.34% |
| Johnson & Johnson EC | $668M | 10.22% |
| Abbvie Inc. EC | $269M | 4.11% |
| Gilead Sciences Inc. EC | $259M | 3.96% |
| Merck & Co., Inc EC | $232M | 3.55% |
| Amgen Inc. EC | $228M | 3.49% |
| Unitedhealth Group Inc. EC | $199M | 3.04% |
| Intuitive Surgical Inc. EC | $161M | 2.46% |
| Abbott Laboratories EC | $158M | 2.43% |
| Danaher Corporation EC | $151M | 2.31% |
| Thermo Fisher Scientific Inc EC | $149M | 2.28% |
| Edwards Lifesciences Corporation EC | $148M | 2.26% |
| Vertex Pharmaceuticals Incorporated EC | $136M | 2.08% |
| Medtronic PLC EC | $131M | 2.00% |
| Stryker Corporation EC | $129M | 1.98% |
| Teva Pharmaceutical Industries Ltd. EC | $118M | 1.80% |
| Cencora Inc EC | $98.9M | 1.51% |
| Boston Scientific Corporation EC | $98.7M | 1.51% |
| Astrazeneca PLC EC | $94.6M | 1.45% |
| Argenx Se EC | $93.1M | 1.42% |
| Mckesson Corp. EC | $78.7M | 1.20% |
| Roche Holding Ag EP | $70.3M | 1.08% |
| Biogen Inc EC | $69.9M | 1.07% |
| Alnylam Pharmaceuticals Inc. EC | $69M | 1.06% |
| Regeneron Pharmaceuticals, Inc. EC | $68.5M | 1.05% |
| Bristol-myers Squibb Company EC | $68.4M | 1.05% |
| Hca Healthcare Inc EC | $66.6M | 1.02% |
| Blackrock Funds Iii STIV | $57.5M | 0.88% |
| Exact Sciences Corporation EC | $56.7M | 0.87% |
| Rhythm Pharmaceuticals Inc EC | $50M | 0.76% |
| Idexx Laboratories Inc. EC | $49M | 0.75% |
| Dexcom Inc EC | $48.7M | 0.75% |
| Penumbra Inc. EC | $45.9M | 0.70% |
| Insmed Inc EC | $45M | 0.69% |
| Novartis Ag EC | $42.4M | 0.65% |
| Incyte Corporation. EC | $40.1M | 0.61% |
| Medline Inc. EC | $40M | 0.61% |
| Waters Corporation EC | $39.7M | 0.61% |
| Blackrock Liquidity Funds STIV | $34.2M | 0.52% |
| Protagonist Therapeutics Inc EC | $34.1M | 0.52% |
| Agilent Technologies Inc. EC | $32.9M | 0.50% |
| Pfizer Inc. EC | $32.8M | 0.50% |
| Nuvalent Inc EC | $32.2M | 0.49% |
| Cogent Biosciences Inc. EC | $31.9M | 0.49% |
| Guardant Health Inc EC | $31.6M | 0.48% |
| Revolution Medicines Inc EC | $30.9M | 0.47% |
| Moderna Inc EC | $30M | 0.46% |
| Galderma Group Ag EC | $28.9M | 0.44% |
| Cvs Health Corp EC | $28.7M | 0.44% |
| Elevance Health Inc. EC | $28.4M | 0.43% |
| United Therapeutics Corporation EC | $28.1M | 0.43% |
| Natera Inc EC | $27.1M | 0.41% |
| Iqvia Holdings Inc. EC | $25.2M | 0.39% |
| The Cooper Companies, Inc. EC | $24.5M | 0.38% |
| Centene Corp. EC | $24.5M | 0.37% |
| Biomarin Pharmaceutical Inc. EC | $19.9M | 0.30% |
| Illumina Inc EC | $19.6M | 0.30% |
| Ge Healthcare Technologies Inc. EC | $19.1M | 0.29% |
| Bruker Corporation EC | $18.9M | 0.29% |
| Veeva Systems Inc EC | $18.1M | 0.28% |
Showing top 60 of 165 holdings.
Loading...
